Dose optimization of duvelisib in patients with relapsed or refractory peripheral T-cell lymphoma from the phase 2 PRIMO trial: Selection of regimen for the dose-expansion phase Meeting Abstract
| Authors: | Horwitz, S. M.; Mehta-Shah, N.; Pro, B.; Jacobsen, E. D.; Casulo, C.; Brammer, J. E.; Haney, J.; Youssoufian, H.; Weaver, D. T.; Baglio, M.; Soto, J.; Narasimhan, N.; Zain, J. |
| Abstract Title: | Dose optimization of duvelisib in patients with relapsed or refractory peripheral T-cell lymphoma from the phase 2 PRIMO trial: Selection of regimen for the dose-expansion phase |
| Meeting Title: | 61st Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Dec 7-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-11-13 |
| Language: | English |
| ACCESSION: | WOS:000577160402120 |
| DOI: | 10.1182/blood-2019-121401 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1567 -- Source: Wos |
